Please login to the form below

Not currently logged in
Email:
Password:

Novimmune

This page shows the latest Novimmune news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi

Sobi gained the PRV during the acquisition of Novimmune’s Gamifant (emapalumab) related business  earlier this year.

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Sosei appoints CFO Sosei appoints CFO

    Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

  • Novimmune appoints Guillaume de Sampaïo Novimmune appoints Guillaume de Sampaïo

    Prior to joining Novimmune he served at Danish biotech firm Forward Pharma, where he created and managed its clinical development group. ... Guillaume de Sampaïo will help us to further advance Novimmune as we move closer to the market with our lead

  • Novimmune expands senior management team Novimmune expands senior management team

    Fleurant joins Novimmune with 20 years of quality expertise in life sciences, most recently having served as head of quality affairs at Alvotech, an Icelandic biosimilars specialist. ... Eduard Holdener, chairman and chief executive of Novimmune, said:

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics